Levetiracetam Winthrop

Levetiracetam, the active ingredient in Levetiracetam Winthrop, is an anticonvulsant presented as an oral tablet for oral use. It is indicated for the treatment of partial‑onset, generalized tonic‑clonic, and myoclonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Winthrop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing EU‑market quality medication to meet global therapeutic needs. The company ensures regulatory compliance, rigorous quality control, and reliable logistics for its pharmaceutical portfolio.

Levetiracetam is an antiepileptic drug that reduces seizure activity across several seizure types.

Partial‑onset seizures: helps control focal seizures and reduce frequency. Generalized tonic‑clonic seizures: decreases occurrence of convulsive episodes. Myoclonic seizures: reduces sudden muscle jerks associated with epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue - Dizziness - Headache - Irritability

Serious or Rare Side Effects: - Severe allergic reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior - Life‑threatening skin rash (e.g., toxic epidermal necrolysis)

Before initiating therapy, consider the following safety measures.

Renal impairment: adjust dose based on renal function. Hepatic disease: monitor liver enzymes regularly. Psychiatric symptoms: observe for mood changes or aggression. Pregnancy: risk unknown, weigh benefits against potential risks. Concomitant CNS depressants: may increase sedation. Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam can interact with other medicines; review the following.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam efficacy. - Phenytoin: may lower levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Alcohol: can enhance central nervous system depression. - Other antiepileptics (e.g., valproate): monitor seizure control. - CYP450 inhibitors/inducers: although levetiracetam is not metabolized by CYP enzymes, unexpected effects should be observed.